AIM Breakfasts

AIM BREAKFAST – 25th November 2016

Set Menu AIM:

Total number of AIM Companies (Incl Susp): 993

Total number of AIM Companies trading: 968*
* As at 24 November 2016

Dish of the Day:

No AIM Joiners Today

Off the Menu:

No AIM Leavers Today

Set Menu ISDX Growth:

Total number of ISDX Growth Market Companies (Incl Susp): 83*

Total number of ISDX Growth Market Companies trading: 78*
* As at 24 November 2016

Dish of the Day:

No ISDX Growth Market Joiners Today

Off the Menu:

No ISDX Growth Market Leavers Today

What’s Cooking in the IPO Kitchen?

i3 Energy Investment—According to its investor Glenwick (GWIK.L) i3 will seek an AIM admission once its license has been approved by the UK Oil & Gas Authority

Walls & Futures REIT — Has raised £1m at £1 to acquire, refurbish or develop residential properties in the UK . Due to arrive on ISDX on 29 November

Diversified Oil & Gas— Schedule One now out. $60m to be raised. Expected admission 6 December.

Creo Medical Group —UK based medical device company focused on surgical endoscopy, a recent development in minimally invasive surgery. Admission due 7 December. Fundraising details TBA.

Breakfast Buffet

Sandal (ISDX:SAND) 30.5p £5m

AGM Statement from the designer, developer & manufacturer of electronics. “Trading since the start of the financial year has been in-line with the  Board’s expectations and is within the forecasts contained in Daniel  Stewart’s research note published on 18 October 2016. Since the end of the financial year under review, the Company has announced the integration of its Energenie MiHome products with the Nest Intelligent Learning Thermostat and the Amazon Echo range of home automation products which should enable the Company to maximise sales for its MiHome Home Automation product range.”

InnovaDerma* (IDP.L) 75p £7.76m (Main Market)

The UK developer of ‘at-home’ and clinically proven treatments for hair loss, hair care, self-tanning and skin rejuvenation, has raised £539,999.60 before expenses at a price of 70p, with institutional shareholders. The net proceeds of the fundraising will provide the Company with working capital to fund growth into European and US markets and improve supply chain management to meet growing demand for Skinny Tan, a premium self-tanner brand that contains a natural tanning active, to tan and reduce the visible appearance of cellulite

Regency Mines (RGM.L) 0.47p £1.56m

The natural resource development and investment company announced a Heads of Terms has been signed by  acquire a significant shareholding in Carbon Minerals Corporation Company which has entered into an agreement to acquire the Rosa metallurgical coal mine located in Alabama, in the Warrior Coal Basin.  CMC paying $1.65m. Regency to conditionally pay $250k in total for 20%. Phase 1 of the Rosa Mine project contains Proven Reserves of 453,000 tons of coal at an average 14,070 BTU/lb with 5.14% average moisture content and 4.45% average ash content.

Manx Financial group (MFX.L) 7.12p £7.27m

Edgewater Associates Limited, a wholly owned subsidiary and the Isle of Man’s leading retail IFA, has entered into an agreement with Knox Financial Services Limited, to acquire the majority of the Island’s IFA business held by Knox. The initial acquisition includes approximately 4,000 clients together with 6 members of staff, generating an anticipated annual renewal income of up to £0.3 million. An option has been entered to buy the remainder of the vendor’s IFA business.  The combined consideration of £1.7m is 4x renewal income. Accretive to normalised operating profit by circa £0.4m.

Origin Enterprises (OGN.L) €6.05 €759.8m

Trading update from the Agri –Services Group for the quarter to October 2016. Origin had an encouraging start to the 2017 financial year with all businesses performing well in the seasonally quiet first quarter. A combination of generally favourable weather conditions and an improved planning environment for primary producers in the period in key geographies led to good early season activity levels on-farm, resulting in higher demand for the Group’s services and inputs. Revenue up 11% to €333.6m. Positive outlook despite subdued sector sentiment. FYJul17E rev £1.5bn and PBT of £62.2m.

Zambeef Products (ZAM.L) 19.63p £48.67m

Record results from the fully integrated agri-business with operations in Zambia, Nigeria and Ghana. Profit After Tax of ZMW157.4 million (USD14.5 million), compared with a loss of ZMW54.6 million (USD7.7 million) for the same period last year; Group debt reduced by 23.6 per cent. from USD72 million (2015) to USD55 million (2016); Zambeef now has the ability once again to invest in growing its business, accelerate the roll-out of its new macro stores and expand its production capacity in order to meet the growing demand for its products, both in Zambia and in the surrounding SADC/COMESA regions.

Gresham House Strategic (GHS.L) 752.5p £27.75m

H1 Sep16 results from GHS, which invests primarily in UK and European smaller public companies.  New investment of growth capital in Northbridge Industrial Services plc and subsequent increase in stake to 10.9% . Significant second investment of growth capital in Be Heard backing the acquisition of MMT Digital, increasing stake to 10.6%. NAV/share up 8.5% outperforming benchmark by 2%. Circa 15p per share available for return to shareholders according to the policy to return half of net profit on realised gains on investment.

Ithaca Energy (IAE.L) 83p £342.3m

Update on the on-going Stella field commissioning programme and the expected schedule for start-up of production.  Activities on the offshore commissioning programme for the FPF-1 floating production facility are well advanced and preparation for start-up of the Stella field is on-going.  During routine inspections, faults on a number of electrical junction boxes on the vessel’s processing facilities have been identified and a programme of necessary repairs is underway.  All other preparations are on plan.  Start-up is now anticipated in early January 2017, upon completion of this additional work.

Proxama PLC (PROX.L) 1.03p £17.64m

The mobile proximity marketing experts, today announced that Alzheimer’s Research UK has used beacons to promote its ‘Santa Forgot’ Christmas campaign to boost awareness and donations for the charity. The ‘Santa Forgot’ campaign kicked off with national TV and multimedia promotion last week. The charity used Proxama’s beacon network to share their promotional video across taxis, cinemas and convenience stores – both in-app and via the Physical Web – to Londoners via their smartphones.

CloudTag (CTAG.L) 22.25p £32.24m

The company that brings personal monitoring to the wellbeing, fitness and digital health markets, has entered into an agreement with Griffin International Companies Inc. which is part of the CITIES Market Studios Group (CITIES), for it to act as the Company’s sole and exclusive sales representative to sell all of the Company’s products to customers identified by CITIES. CITIES is believed to be one of the largest commercialisation and distribution players with over 30 years’ experience in North America.  There are no forecasts in the market.

Head Chef:

Derren Nathan
0203 764 2344
derren.nathan@hybridan.com

*A corporate client of Hybridan LLP

Disclaimer

This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific entity and is not a personal recommendation to anyone. Recipients should make their own investment decisions based upon their own financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.

The information contained in this document is based on materials and sources that are believed to be reliable; however, they have not been independently verified and are not guaranteed as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information in this document nor should it be relied upon as such.

Any and all opinions expressed are current opinions as of the date appearing on this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, directors, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.

This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, does not constitute “independent investment research” for the purposes of the Financial Conduct Authority rules. The individuals who prepared this document may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, directors, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.

In the UK, this document is directed at and is for distribution only to persons who (i) fall within Article 19(5) (persons who have professional experience in matters relating to investments) or Article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended) or (ii) are Professional Clients or Eligible Counterparties (as those terms are defined in the rules of the Financial Conduct Authority) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as “relevant persons”). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by persons who would be classified as Retail Clients (as defined by the rules of the Financial Conduct Authority).

Neither this document nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of UK or US securities law, or the law of any such other jurisdictions.

Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, directors, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.

Neither the whole nor any part of this document may be duplicated in any form or by any means. Neither should this document, or any part thereof, be redistributed or disclosed to anyone without the prior consent of Hybridan LLP.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”.